To guide your summer getaway book selections, try this formula: E=FB²
For the past several months, Majority Leader Bill Frist had the job of overseeing in the U.S. Senate six proposals to escalate embryonic stem-cell research. In the Bush administration's eyes, Mr. Frist's job was simple: Stop all six and spare the president from having to veto a bill for the first time in his four-and-a-half years in office.
Mr. Frist took the podium well before 9 a.m. on a drowsy Friday-a day regarded by many as a congressional travel day-to announce before a sparse Senate audience that he had changed his mind on embryonic stem-cell research. After supporting Mr. Bush's nuanced research approach for four years, the former transplant surgeon announced July 29 that he would now support more aggressive study of embryos.
"To derive embryonic stem cells, an embryo-which many, including myself, consider nascent human life-must be destroyed," Mr. Frist acknowledged. "But I also strongly believe . . . that embryonic stem cells uniquely hold specific promise for some therapies and potential cures that adult stem cells cannot provide."
Senators backing further research that destroys embryos rushed to praise Mr. Frist. Pennsylvania Republican Sen. Arlen Specter said Mr. Frist's speech was "the most important speech made this year, and perhaps the most important speech made in years." Conservative jaws hit the floor. Wendy Wright, a senior policy director for Concerned Women for America, said she felt like a close friend had disappointed her. "I am surprised," Ms. Wright said. "And [his change of heart is] not from a lack of information; it's core values."
The Tennessee lawmaker broke ranks with the Bush administration policy of allowing research on what has become only 22 lines of embryonic stem cells, lines in existence before President Bush outlawed government funding for embryonic stem-cell research in 2001. What's left is a race between those who seek to rush through whatever permissive legislation they can, and those touting preliminary evidence-including a recent report from a panel of bioethicists-that the benefits of embryonic stem-cell research can be replicated without the cost in embryonic lives.
Mr. Frist's announcement came the day before Congress' August recess. It bolsters scientists who believe embryonic stem cells, factories for creating every tissue in the body, can cure diseases such as Parkinson's, Alzheimer's, and juvenile diabetes. If the Stem Cell Research Enhancement Act, which Mr. Frist now supports, passes, it will allow researchers access to federal funding to derive new stem cells from unused embryos left over from in vitro fertilization (IVF).
The bill passed in the House in May with a vote of 238-194, then sat untouched in the Senate for two months. Many senators speculated Mr. Frist would let it die without bringing it to the floor for debate, especially given his support of Mr. Bush, who promised to veto the bill.
But Mr. Frist instead reverted to his 2001 stance on stem cells, which he articulated to the Senate when researchers first began experimenting with embryonic stem cells. As a surgeon, Mr. Frist's medical perspective carried weight with both Republicans and Democrats. Mr. Frist said he initially supported the more restrictive Bush policy because it would continue to make stem cells from more than 70 embryos available to researchers. Researchers have since bemoaned the quality of those stem cells and pushed Mr. Bush to relax the limits on federal funding.
As politicians, including some Republicans, have joined the scientists in pressuring the president, Mr. Frist and other pro-lifers are changing their positions. Fifty Republicans, many claiming solid pro-life credentials, voted for the House version of the Stem Cell Research Enhancement Act. Meanwhile, as chairman of the subcommittee on Labor, Health and Human Services, and Education, Mr. Specter threatened to pass the stem-cell bill by attaching it as an amendment to a health budget bill. In his speech, Mr. Frist hinted that the threats had worked.
"It's only fair, on an issue of such magnitude, that senators be given the respect and courtesy of having their ideas in this arena considered separately and cleanly, instead of in a whirl of amendments and complicated parliamentary maneuvers," Mr. Frist said.
The move raises questions about Mr. Frist's political future. Speculation about his intent to run for president in 2008 has flared since the speech. "Maybe he imagines that if he can only give in on this kind of issue to the moderate wing of the party, then he can position himself as an alternative to someone in the Christian right," said Graham Walker, professor of political science at Oklahoma Wesleyan University.
If so, Mr. Frist might have to vie for the limelight with other Republican centrists-such as former New York City mayor Rudy Giuliani, New York Gov. George Pataki, and Sen. John McCain-without support from the party's conservative base. "He has just guaranteed that the core of the party will be utterly hostile to him for the rest of his career," said Mr. Walker.
Ms. Wright agrees, but qualifies her criticism of the Tennessee Republican. "He's been very good on other things," she said. "We're not blackballing him." Still, she points to an emerging question she says conservatives eventually need to answer. Can someone be pro-life and support embryonic stem-cell research? Mr. Frist and other conservative supporters of the research say their pro-life values lead them to support the study of intact embryos bound for destruction anyway. Ms. Wright disagrees. "When you talk about eternal values, this is a big issue," she said. "There are those that say that the advance of science is paramount over what is moral or right. . . . This stance harms him immeasurably, and I'd say irrevocably."
The bill has enough votes to pass in the Senate, and Republicans are already bracing for its collision with the White House. After Mr. Frist's speech, White House spokesman Scott McClellan reaffirmed Mr. Bush's intent to veto the bill. "The Republican party, I think, is headed for a fissure," Mr. Walker said.
Liberal advocacy groups are banking on it. Pro-research groups spent the summer bombarding Congress with pleas from the sick and dying. One such group, the Juvenile Diabetes Research Foundation, supports all embryonic stem-cell research, including research on cells that are the products of human cloning. In June, the foundation's chairwoman, Mary Tyler Moore, led 150 diabetic children in a march on the Capitol. Some participants, poster children ages 2 to 17, weren't old enough to say "embryonic." But they had talking points. "I just want to feel like a normal kid without pricking my finger 2,000 times a year or injecting myself with insulin 11 hundred times a year," 10-year-old Aaron Jones testified to U.S. senators on June 21.
Ignored are proposals by a growing group of scientists, such as Dr. William Hurlbut at Stanford University, who give pro-lifers a way to say yes to both Aaron Jones and unborn children in IVF clinics. Dr. Hurlbut says a scientific technique called altered nuclear transfer could produce stem cells with the same properties as those derived from embryos.
Altered nuclear transfer (ANT) is similar to cloning in that it puts the nucleus of an adult cell into an enucleated human egg, or oocyte. But before the transfer, scientists turn off the genetic switch in the nucleus that directs the egg to become a baby. What results is an unorganized mass of cells, some of which look and behave just like embryonic stem cells.
Dr. Hurlbut told WORLD that ANT "may represent our last best hope of framing an ethical way to go forward with stem-cell research." The President's Council on Bioethics, of which Dr. Hurlbut is a member, presented ANT as one of four feasible alternatives to embryo destruction in a May 10 White Paper. Scientists have continued to come up with improved variations of the proposals in the White Paper even since the council published it.
Mr. Frist's speech undercuts ANT and the hopeful recommendations of the president's bioethics council, despite his claim to support alternatives like ANT. In his floor speech he called it "research worth supporting," noting it was "still preliminary today." For the research community, however, new proposals follow the money, which Mr. Frist would now direct toward research that destroys embryos.
Mr. Specter predicted Mr. Frist's speech would bring both sides of the embryonic stem-cell debate together. But in the days following the speech, the Republican divide only seemed to grow as people on opposing sides of the debate lambasted one another.
Ms. Wright said Mr. Frist has failed to consider the bloc he's aligned himself with-research proponents who take a study-first, ask-questions-later approach. "Their ethical line in the sand gets washed away with every new pressure," Ms. Wright said. "We already know what the proponents of this want: a class of humans they can experiment on."